Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Frontline Treatment of CD30+Peripheral T-Cell Lymphomas with Brentuximab Vedotin in Combination with CHP: 3-Year Durability and Survival Follow-up Horwitz, S. M., Shustov, A. R., Forero-Torres, A., Bartlett, N. L., Advani, R., Pro, B., Chen, R., Davies, A. J., Illidge, T., Huebner, D., Kennedy, D. A., Fanale, M. A. AMER SOC HEMATOLOGY. 2015
View details for Web of Science ID 000368019005015